AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 178 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $258,000 | -16.5% | 5,600 | 0.0% | 0.01% | -17.6% |
Q2 2021 | $309,000 | +6.9% | 5,600 | 0.0% | 0.02% | 0.0% |
Q1 2021 | $289,000 | +18.9% | 5,600 | 0.0% | 0.02% | +13.3% |
Q4 2020 | $243,000 | -18.7% | 5,600 | 0.0% | 0.02% | -37.5% |
Q2 2020 | $299,000 | +12.0% | 5,600 | 0.0% | 0.02% | +26.3% |
Q4 2019 | $267,000 | -4.3% | 5,600 | 0.0% | 0.02% | -13.6% |
Q2 2019 | $279,000 | -26.2% | 5,600 | 0.0% | 0.02% | -29.0% |
Q1 2019 | $378,000 | +46.5% | 5,600 | 0.0% | 0.03% | +29.2% |
Q4 2018 | $258,000 | -40.3% | 5,600 | 0.0% | 0.02% | -31.4% |
Q3 2018 | $432,000 | -8.5% | 5,600 | 0.0% | 0.04% | -12.5% |
Q2 2018 | $472,000 | +3.1% | 5,600 | 0.0% | 0.04% | -2.4% |
Q1 2018 | $458,000 | +43.1% | 5,600 | 0.0% | 0.04% | +41.4% |
Q4 2017 | $320,000 | – | 5,600 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
NORTHCAPE WEALTH MANAGEMENT, LLC | 10,510 | $241,415 | 0.09% |